Skip to content

Ernexa Therapeutics Inc.

ERNAW· NasdaqCore metricsCIK 748592

Pharmaceutical preparations551 peers

Close
Oct 29, 2026 · +0.00%
Market cap
—
no share count on file
Filings
1,020
$582.00K
FY 2024+755.9% FY24 yoy
-$2.94M
Q3 2026N/M FY25 yoy
-$2.99M
Q3 2026N/M FY25 yoy
-$9.59M
Q3 2026derivedN/M FY25 yoy
-$1.89
Q3 2026N/M FY25 yoy
$5.58M
Q3 2026+9.0% FY25 yoy

Price

$0.0370.00%$0.07since Feb 6, 2026
Oct 29, 2026 · Official close
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$582.00KFY 2024
$26.05M0FY 2012FY 2017FY 2024
PeriodEndedValueKindSource trail
FY 20242024-12-31$582,000reported
FY 20232023-12-31$68,000reported
FY 20222022-12-31$0reported
FY 20202020-12-31$5,800,000reported
FY 20192019-12-31$19,806,000reported
FY 20182018-12-31$23,335,000reported
FY 20172017-12-31$21,274,000reported
FY 20162016-12-31$22,312,000reported
FY 20152015-12-31$24,519,000reported
FY 20142014-12-31$26,046,000reported
FY 20132013-12-31$23,749,000reported
FY 20122012-12-31$24,064,000reported

Segments

Revenue by Geography, FY2019 to FY2020FY2019United States · FY2019 · $19.15MCanada · FY2019 · $653.00KFY2020United States · FY2020 · $5.48MCanada · FY2020 · $320.00K
LineFY2020ShareChange
United States$5.48M94%−71.4%
Canada$320.00K5.5%−51.0%
Total$5.80M

From the 10-K filed Mar 11, 2021ERNAW

Pharmaceutical preparations

Ernexa Therapeutics Inc. is the 468th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Ernexa Therapeutics Inc. · CIK 748592 · Engraved from SEC EDGAR